Health-related quality of life (HRQoL) outcomes from the randomized, double-blind phase 3 KEYNOTE-671 study of perioperative pembrolizumab for early-stage non-small-cell lung cancer (NSCLC) Meeting Abstract
| Authors: | Garassino, M. C.; Wakelee, H. A.; Spicer, J.; Liberman, M.; Kato, T.; Tsuboi, M.; Lee, S. H.; Chen, K. N.; Dooms, C. A.; Majem, M.; Eigendorff, E.; Martinengo, G. L.; Bylicki, O.; Rodriguez-Abreu, D.; Chaft, J. E.; Yang, J.; Arunachalam, A.; Norquist, J. M.; Keller, S. M.; Gao, S. |
| Abstract Title: | Health-related quality of life (HRQoL) outcomes from the randomized, double-blind phase 3 KEYNOTE-671 study of perioperative pembrolizumab for early-stage non-small-cell lung cancer (NSCLC) |
| Meeting Title: | 2024 ASCO Annual Meeting |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 42 |
| Issue: | 16 Suppl. |
| Meeting Dates: | 2024 May 31-Jun 4 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2024-06-01 |
| Language: | English |
| ACCESSION: | WOS:001275557401805 |
| PROVIDER: | wos |
| DOI: | 10.1200/JCO.2024.42.16_suppl.8012 |
| Notes: | Meeting Abstract: 8012 -- Source: Wos |
